|
T5697 |
BMS-1166
|
|
PD-1/PD-L1
|
|
BMS-1166 is a potent PD-1/PD-L1 interaction inhibitor. |
|
T40111L |
BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride
|
|
PD-1/PD-L1
|
|
BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride is a resorcinol di-Ph ether scaffold-based programmed cell death-1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitor that inhibits the PD-1/PD-L1 interaction wi... |
|
T40110 |
BMS-1166-N-piperidine-COOH
|
|
|
|
BMS-1166-N-piperidine-COOH is a chemical compound that functions as the BMS-1166-based moiety. It binds to the E3 ligase ligand through a linker, leading to the formation of PROTAC PD-1/PD-L1 degrader-1, which facilitate... |
|
T14670 |
BMS-1166 hydrochloride
|
|
Others
|
|
Motixafortide (BKT140 4-fluorobenzoyl) is an antagonist of CXCR4 (IC50: 1 nM). BMS-1166 hydrochloride is an inhibitor of PD-1/PD-L1 interaction (IC50: 1.4 nM). BMS-1166 rivalries the inhibitory effect of PD-1/PD-L1 immun... |
|
T40111 |
BMS-1166-N-piperidine-CO-N-piperazine
|
|
|
|
BMS-1166-N-piperidine-CO-N-piperazine is a chemical compound that contains a PD-1/PD-L1 immune checkpoint ligand and a PROTAC linker. It can be utilized in the synthesis of PROTAC PD-1/PD-L1 degrader-1, which effectivel... |
